Css LLC Biomarin Pharmaceutical Inc Call Options Transaction History

Css LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $388,596 - $471,588	-5,200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $373,724 - $681,356	5,200 New	5,200 $395,000
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $617,078 - $816,739	-7,700 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $272,368 - $306,588	-2,900 Reduced 27.36%	7,700 $747,000
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $159,621 - $207,963	2,100 Added 24.71%	10,600 $999,000
Q1 2018 May 15, 2018	SELL	$77.67 - $92.63 $427,185 - $509,465	-5,500 Reduced 39.29%	8,500 $689,000
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $1.13 Million - $1.33 Million	14,000	14,000 $1.3 Million

635

178M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.